BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 38446668)

  • 21. Mosaic deletion of claudin-5 reveals rapid non-cell-autonomous consequences of blood-brain barrier leakage.
    Vázquez-Liébanas E; Mocci G; Li W; Laviña B; Reddy A; O'Connor C; Hudson N; Elbeck Z; Nikoloudis I; Gaengel K; Vanlandewijck M; Campbell M; Betsholtz C; Mäe MA
    Cell Rep; 2024 Mar; 43(3):113911. PubMed ID: 38446668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CLDN5 gene at the blood-brain barrier in health and disease.
    Hashimoto Y; Greene C; Munnich A; Campbell M
    Fluids Barriers CNS; 2023 Mar; 20(1):22. PubMed ID: 36978081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The region-selective regulation of endothelial claudin-5 expression and signaling in brain health and disorders.
    Chiba H; Ichikawa-Tomikawa N; Imura T; Sugimoto K
    J Cell Physiol; 2021 Oct; 236(10):7134-7143. PubMed ID: 33694168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifying the blood-brain barrier by targeting claudin-5: Safety and risks.
    Wakayama E; Kuzu T; Tachibana K; Hirayama R; Okada Y; Kondoh M
    Ann N Y Acad Sci; 2022 Aug; 1514(1):62-69. PubMed ID: 35508916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CLDN5: From structure and regulation to roles in tumors and other diseases beyond CNS disorders.
    Ling Y; Kang X; Yi Y; Feng S; Ma G; Qu H
    Pharmacol Res; 2024 Feb; 200():107075. PubMed ID: 38228255
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 27.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.